Prague Med. Rep. 2021, 122, 73-79
https://doi.org/10.14712/23362936.2021.8
Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome
References
1. , S., Gutiérrez-Salmerón, M. T., Buenadía-Eisman, A., Girón-Prieto, M. S., Naranjo-Sintes, R. (2011) Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia. J. Am. Acad. Dermatol. 65(1), 48–53.
<https://doi.org/10.1016/j.jaad.2010.05.002>
2. , A., La Vignera, S., Rego, R., Gambineri, A., Nappi, A. E., Calogero, A. E., Ferlin, A. (2020) Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions. Front. Endocrinol. (Lausanne) 11, 516.
<https://doi.org/10.3389/fendo.2020.00516>
3. , R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., Boots, L. R. (2004) Androgen excess in women: Experience with over 1000 consecutive patients. J. Clin. Endocrinol. Metab. 89(2), 453–462.
<https://doi.org/10.1210/jc.2003-031122>
4. , G. A., Givens, J. R., Kitabchi, A. E. (1980) Correlation of hyperandrogenism with hyperinsulinismus in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 50(1), 113–116.
<https://doi.org/10.1210/jcem-50-1-113>
5. , R., La Vignera, S., Condorelli, R. A., Calogero, A. E. (2017) Glycolipid and hormonal profiles in young men with early-onset androgenetic alopecia: a meta-analysis. Sci. Rep. 7(1), 7801.
<https://doi.org/10.1038/s41598-017-08528-3>
6. , R., Condorelli, R. A., Mongioì, L. M., La Vignera, S., Calogero, A. E. (2018) Does a male polycystic ovarian syndrome equivalent exist? J. Endocrinol. Invest. 41(1), 49–57.
<https://doi.org/10.1007/s40618-017-0728-5>
7. , R., Condorelli, R. A., Dall’Oglio, F., La Vignera, S., Mongioì, L. M., Micali, G., Calogero, A. E. (2020) Increased DHEAS and decreased total testosterone serum levels in a subset of men with early-onset androgenetic alopecia: Does a male PCOS-equivalent exist? Int. J. Endocrinol. 2020, 1942126.
<https://doi.org/10.1155/2020/1942126>
8. , A. H., Chan, K. L., Short, F., White, D., Williamson, R., Franks, S. (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf.) 38(6), 653–658.
<https://doi.org/10.1111/j.1365-2265.1993.tb02150.x>
9. , H. E., Spellacy, W. N., Prem, K. H., Cohen, W. D. (1968) Hereditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 100(3), 371–387.
<https://doi.org/10.1016/S0002-9378(15)33704-2>
10. , F., Cerana, M. C., D’urso, G., Genovese, F., Palumbo, M. (2019) Male PCOS equivalent and nutritional restriction: Are we stepping forward? Med. Hypotheses 126, 1–3.
<https://doi.org/10.1016/j.mehy.2019.03.003>
11. , F., Ciotta, L., Monteleone, M., Palumbo, M. (2020) Male equivalent of polycystic ovarian syndrome, metabolic and clinical aspects. Int. J. Fertil. Steril. 14(2), 79–83.
12. , D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., Legro, R. S. (2015) Scientific statement on diagnostic criteria, epidemiology and molecular genetics of polycystic ovarian syndrome. Endocr. Rev. 36(5), 487–525.
<https://doi.org/10.1210/er.2015-1018>
13. , M., Stárka, L. (2006) The existence of male equivalent of polycystic ovary syndrome – The present state of issue. Prague Med. Rep. 107(1), 17–25.
14. , M., Čermáková, I., Hill, M., Vaňková, M., Šámalíková, P., Stárka, L. (2004) What may be the markers of the male equivalent of polycystic ovary syndrome? Physiol. Res. 53(3), 287–294.
15. , B. C., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S., Boivin, J., Petraglia, F., Wijeyeratne, C. N., Norman, R. J., Dunaif, A., Franks, S., Wild, R. A., Dumesic, D., Barnhart, K. (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97(1), 28–38.e25.
<https://doi.org/10.1016/j.fertnstert.2011.09.024>
16. , D., Purdie, A. W. (1979) The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin. Endocrinol. (Oxf.) 11(3), 291–300.
<https://doi.org/10.1111/j.1365-2265.1979.tb03077.x>
17. , J. R., Andersen, R. N. (1975) Letter: Serum testosterone in the polycystic ovary syndrome. Am. J. Obstet. Gynecol. 121(8), 1124–1125.
<https://doi.org/10.1016/S0002-9378(16)33609-2>
18. , J. G., Mancillas-Adame, L. G., Fernández-Reyes, M., Gómez-Flores, M., Lavalle-González, F. J., Ocampo-Candiani, J., Villarreal-Pérez, J. Z. (2009) Androgenetic alopecia and insulin resistance in young men. Clin. Endocrinol. (Oxf.) 71(4), 494–499.
<https://doi.org/10.1111/j.1365-2265.2008.03508.x>
19. , A., Obhrai, M. S., Clayton, R. N. (1999) Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families. J. Clin. Endocrinol. Metab. 84(1), 38–43.
<https://doi.org/10.1210/jcem.84.1.5382>
20. , F., Nambiar, A., Vijayaraghavan, S. (2013) Androgenetic alopecia: an update. Indian J. Dermatol. Venereol. Leprol. 79, 613–625.
<https://doi.org/10.4103/0378-6323.116730>
21. , R. S. (2000) Is there a male phenotype in polycystic ovary syndrome families? J. Pediatr. Endocrinol. Metab. 13, 1307–1309 (Suppl. 5).
22. , A., Bidzińska-Speichert, B., Tworowska-Bardzińska, U., Krępuła, K. (2011) Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Endokrynol. Pol. 62(2), 129–133.
23. , O., Magnus, P., Sandvik, L., Høglo, S. (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 28(1), 23–30.
<https://doi.org/10.1159/000293493>
24. , L., Villarreal-Villarreal, C. D., Ortiz-López, R., Ocampo-Cadiani, J., Rojas-Martínez, A. (2018) Genetic and molecular aspects of androgenetic alopecia. Indian J. Dermatol. Venereol. Leprol. 84(3), 263–268.
<https://doi.org/10.4103/ijdvl.IJDVL_262_17>
25. , V., Koskela, P., Keinanen-Kiukaanniemi, S. (2000) Early androgenetic alopecia as a marker of insulin resistance. Lancet 356(9236), 1165–1166.
<https://doi.org/10.1016/S0140-6736(00)02763-X>
26. , M. W., Kkempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K. H., Arlt, W. (2017) 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 102(3), 840–848.
<https://doi.org/10.1210/jc.2016-3285>
27. , S., Chander, R., Jain, A., Garg, T., Yadav, P. (2016) A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 152(9), 986–991.
<https://doi.org/10.1001/jamadermatol.2016.1776>
28. , M., Vítků, J., Kolátorová, L., Vrbíková, J., Vosátková, M., Včelák, J., Dušková, M. (2020) Endocrine disruptors, obesity and cytokines – How relevant are they to PCOS? Physiol. Res. 69, S279–S293 (Suppl. 2).
<https://doi.org/10.33549/physiolres.934521>
29. , M. A., Bell, R. J., Islam, R. M., Karim, M. N., Davis, S. R. (2020) Distribution of body hair in young Australian women and associations with serum androgen concentrations. J. Clin. Endocrinol. Metab. 105(4), dgaa063.
<https://doi.org/10.1210/clinem/dgaa063>
30. , A., Manna, P. R., Tuckey, R. C. (2015) On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids 103, 72–88.
<https://doi.org/10.1016/j.steroids.2015.04.006>
31. , L., Hill, M., Poláček, V. (2000) Hormonal profile in men with premature androgenic alopecia. Sb. Lek. 101(1), 17–22. (in Czech)
32. , L., Čermáková, I., Dušková, M., Hill, M., Doležal, M., Poláček, V. (2004) Hormonal profile of men with premature balding. Exp. Clin. Endocrinol. Diabetes 112(1), 24–28.
<https://doi.org/10.1055/s-2004-815723>
33. , L., Dušková, M., Čermáková, I., Vrbíková, J., Hill, M. (2005) Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? Endocr. Regul. 39, 127–131.
34. , I. F., Leventhal, M. L. (1935) Amenorhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29, 181–186.
<https://doi.org/10.1016/S0002-9378(15)30642-6>
35. , K. H., Bloem, L. M., Africander, D., Schloms, L., Swart, P., Swart, A. C. (2013) 11β-hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: A putative role in castration resistant prostate cancer? Mol. Cell. Endocrinol. 377(1–2), 135–146.
<https://doi.org/10.1016/j.mce.2013.07.006>
36. , A. F., Nanba, A. T., Auchus, R. J. (2018) The rise, fall, and resurrection of 11-oxygenated androgens in human physiology and disease. Horm. Res. Paediatr. 89(5), 284–291.
<https://doi.org/10.1159/000486036>
37. , J., Bendlová, B., Hill, M., Vaňková, M., Vondra, K., Stárka, L. (2002) Insulin sensitivity and ß-cell function in women with polycystic ovary syndrome. Diabetes Care 25(7), 1217–1222.
<https://doi.org/10.2337/diacare.25.7.1217>
38. , C. C. (2009) The skin as an endocrine organ. Dermatoendocrinol. 1(5), 250–252.
<https://doi.org/10.4161/derm.1.5.9499>
